OUTLIER TECHNOLOGY, LLC

Medtech · Private

NeuroSync: an augmented reality neurorehabilitation platform using Neurologic Music Therapy to deliver personalized, adaptive therapeutic interventions for Alzheimer's Disease

Grants
$2.2M
4 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · A Gesture-Powered Software Platform of Neurologic Music Therapy Games and Puzzles: To Stimulate Neuroplasticity and Prolong Functional Independence in Individuals Diagnosed with Alzheimer's Disease$504,505
Federal grantDepartment of Health and Human Services · Phase I · A Gesture-Powered Software Platform of Neurologic Music Therapy Games and Puzzles: To Stimulate Neuroplasticity and Prolong Functional Independence in Individuals Diagnosed with Alzheimer's Disease$249,999
Federal grantDepartment of Health and Human Services · Phase I · A Gesture-Powered Software Platform of Neurologic Music Therapy Games and Puzzles: To Stimulate Neuroplasticity and Prolong Functional Independence in Individuals Diagnosed with Alzheimer's Disease$55,000
Federal grantDepartment of Health and Human Services · Phase II · NeuroSync: a data-driven, music-based augmented reality neurorehabilitation platform of games & puzzles to stimulate neuroplasticity and prolong functional independence in Alzheimer's Disease patients$1,383,492
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1809Savage Medical Inc.——
1810G5 BIOLOGICAL INNOVATIONS LLC——
1811THERMOBIONICS LLC——
1812OUTLIER TECHNOLOGY, LLC——
1813MEMBRANE SCIENCES, LLC——
1814PLEXISION, INC.——
1815Theranica——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.